Expertise in
11
conditions

Hany A. Soliman

T Wing 2075 Bayview Avenue, 
Toronto, ON, CA 
Expertise in
11
conditions
T Wing 2075 Bayview Avenue, 
Toronto, ON, CA 

Overview

Hany Soliman practices practicing medicine in Toronto, Canada.

Mr. Soliman is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Bone Tumor, Fractured Spine, Metastatic Brain Tumor, and Mastectomy.

He is actively involved in clinical research, co-authoring 224 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

T Wing 2075 Bayview Avenue, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Randomized Phase II Study: Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug, Other
Study Phase: Phase 2
Evaluation of the Ductal Carcinoma In Situ Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
Evaluation of the Ductal Carcinoma In Situ Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
Enrollment Status: Completed
Publish Date: February 19, 2020
View 1 Less Clinical Trial

224 Total Publications

Evaluation of the budget impact of single-inhaler triple therapy (fluticasone furoate/umeclidinium/vilanterol) in patients with moderate to severe asthma in the Saudi healthcare system.
Evaluation of the budget impact of single-inhaler triple therapy (fluticasone furoate/umeclidinium/vilanterol) in patients with moderate to severe asthma in the Saudi healthcare system.
Journal: Journal of medical economics
Published: June 19, 2026

Frequently Asked Questions about Hany A. Soliman

Is Hany A. Soliman a top-rated expert for Brain Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Hany A. Soliman is classified as an Distinguished expert for Brain Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hany A. Soliman participate in research or clinical trials?

Yes. Hany A. Soliman has published 224 articles and abstracts on conditions like Brain Tumor. You can view a list of Hany A. Soliman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Soliman's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile